The overall aim of the study is to monitor near real-time performance of COVID-19 vaccines administered as part of 2023 autumnal vaccination campaigns in the community-dwelling resident population aged ≥65 years in EU/EEA countries to detect any variation in VE, so that public health vaccine...

This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living...